These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12456073)

  • 21. The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach.
    Salahuddin P; Rabbani G; Khan RH
    Cell Mol Biol Lett; 2014 Sep; 19(3):407-37. PubMed ID: 25141979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced glycation endproducts change glutathione redox status in SH-SY5Y human neuroblastoma cells by a hydrogen peroxide dependent mechanism.
    Deuther-Conrad W; Loske C; Schinzel R; Dringen R; Riederer P; Münch G
    Neurosci Lett; 2001 Oct; 312(1):29-32. PubMed ID: 11578838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidirectional inhibition of cortico-hippocampal neurodegeneration by kolaviron treatment in rats.
    Olajide OJ; Asogwa NT; Moses BO; Oyegbola CB
    Metab Brain Dis; 2017 Aug; 32(4):1147-1161. PubMed ID: 28405779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia.
    Wong A; Dukic-Stefanovic S; Gasic-Milenkovic J; Schinzel R; Wiesinger H; Riederer P; Münch G
    Eur J Neurosci; 2001 Dec; 14(12):1961-7. PubMed ID: 11860491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced glycation end products as biomarkers and gerontotoxins - A basis to explore methylglyoxal-lowering agents for Alzheimer's disease?
    Krautwald M; Münch G
    Exp Gerontol; 2010 Oct; 45(10):744-51. PubMed ID: 20211718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced glycation endproducts cause lipid peroxidation in the human neuronal cell line SH-SY5Y.
    Gasic-Milenkovic J; Loske C; Münch G
    J Alzheimers Dis; 2003 Feb; 5(1):25-30. PubMed ID: 12590163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials.
    Drygalski K; Fereniec E; Koryciński K; Chomentowski A; Kiełczewska A; Odrzygóźdź C; Modzelewska B
    Exp Gerontol; 2018 Nov; 113():36-47. PubMed ID: 30266470
    [No Abstract]   [Full Text] [Related]  

  • 29. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.
    Calabrese V; Butterfield DA; Stella AM
    Ital J Biochem; 2003 Dec; 52(4):177-81. PubMed ID: 15141484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Insight in Pathophysiological Mechanism of Alzheimer's Disease and its Management Using Plant Natural Products.
    Firdaus Z; Singh TD
    Mini Rev Med Chem; 2021; 21(1):35-57. PubMed ID: 32744972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains.
    Lüth HJ; Ogunlade V; Kuhla B; Kientsch-Engel R; Stahl P; Webster J; Arendt T; Münch G
    Cereb Cortex; 2005 Feb; 15(2):211-20. PubMed ID: 15238435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection].
    Behl C; Holsboer F
    Fortschr Neurol Psychiatr; 1998 Mar; 66(3):113-21. PubMed ID: 9565761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraneuronal advanced glycation endproducts in presenilin-1 Alzheimer's disease.
    Münch G; Shepherd CE; McCann H; Brooks WS; Kwok JB; Arendt T; Hallupp M; Schofield PR; Martins RN; Halliday GM
    Neuroreport; 2002 Apr; 13(5):601-4. PubMed ID: 11973454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small molecule activators of the Trk receptors for neuroprotection.
    Webster NJ; Pirrung MC
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S1. PubMed ID: 19090982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer's Disease.
    Ali T; Kim T; Rehman SU; Khan MS; Amin FU; Khan M; Ikram M; Kim MO
    Mol Neurobiol; 2018 Jul; 55(7):6076-6093. PubMed ID: 29170981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Inflammatory Pathways in Alzheimer's Disease: A Focus on Natural Products and Phytomedicines.
    Sharman MJ; Verdile G; Kirubakaran S; Parenti C; Singh A; Watt G; Karl T; Chang D; Li CG; Münch G
    CNS Drugs; 2019 May; 33(5):457-480. PubMed ID: 30900203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches.
    Behl C
    Prog Neurobiol; 1999 Feb; 57(3):301-23. PubMed ID: 10096843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The damage signals hypothesis of Alzheimer's disease pathogenesis.
    Fernández JA; Rojo L; Kuljis RO; Maccioni RB
    J Alzheimers Dis; 2008 Jul; 14(3):329-33. PubMed ID: 18599959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress hypothesis in Alzheimer's disease: a reappraisal.
    Praticò D
    Trends Pharmacol Sci; 2008 Dec; 29(12):609-15. PubMed ID: 18838179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.